GlassScriptPhysician profile
Eric Michael Mccallister
NPI 1245763135
$3,771.33
in general payments reported to CMS, 2019-2025
16 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $1,981 · 2021: $210 · 2022: $399 · 2023: $370 · 2024: $276 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,822.00 | 2020 | |
| Smith+Nephew, INC. | $521.62 | 2019-2025 | Grafix Pl, Oasis |
| Organogenesis INC. | $300.23 | 2022-2025 | Apligraf, Puraply Wound Matrix, Puraply |
| Davol INC. | $233.00 | 2023 | Channel Drain |
| Kerecis Limited | $213.38 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $153.05 | 2021-2022 | |
| Inari Medical, INC. | $124.97 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Horizon Therapeutics Plc | $91.24 | 2019 | |
| Paratek Pharmaceuticals, INC. | $79.78 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $58.82 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $55.91 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Arthrex, INC. | $30.71 | 2020 | |
| Next Science LLC | $25.09 | 2023 | Xperience, Blastx, Surgx |
| Lifenet Health | $24.75 | 2025 | Theragenesis Wound Matrix |
| Abbvie INC. | $18.64 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $18.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mccallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.